top medication-assisted weight loss programs with glp-1 support Medical Understanding new weight-loss drugs -

Glucose-dependent insulin secretion & metabolic improvements: GLP-1 improves post-meal insulin secretion and lowers glucagon, which improves glycemia and can reduce metabolic drivers of weight gain

Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(736)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo

Additionally, these medications slow gastric emptying, which prolongs the sensation of fullness after eating and reduces appetite through effects on satiety centres in the brain

BMC Endocr

Second Nature provides HCPC-registered dietitians and AfN-registered nutritionists available five days a week through in-app messaging